Dr. Ted Witek has decades of experience in research, development, and leadership, as well as executive responsibilities as CSO and CEO, and has managed some of the sector’s largest strategic alliances. He is currently a Professor at the University of Toronto, directing the school’s Doctor of Public Health Program.
Previously, Ted served at Boehringer Ingelheim Pharmaceuticals for nearly 25 years, where he held various pharmacology and clinical research positions, including Director of Respiratory and Immunology Clinical Research, leading to his roles as President and CEO of Boehringer Ingelheim’s Canadian and Portuguese operations. He also led the Global Operating Team for Spiriva, serving as Co-Chair of the Global Alliance with Pfizer. Ted also was Chief Scientific Officer and Senior Vice President of Corporate Partnerships at Innoviva (formerly Theravance, Inc.).
Ted has also served on the Board of Directors of Canada’s Research-Based Pharmaceutical Companies (Rx&D), including as Chair of the Health Technology Assessment and Public Relations Committee. He is the author of more than 100 scientific papers, as well as several chapters and books.
Ted holds a Doctor of Public Health from Columbia University, a Master of Public Health from Yale University, and an MBA from Henley Management College in London.